Trial Profile
Study of new therapy in patients with chronic hepatitis C including liver cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura; Thrombocytopenia
- Focus Therapeutic Use
- 18 Apr 2017 New trial record